Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition
By Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton
Complete
,Chapter 01: Drug Definitions, Standards, and Information Sources Willihng
wq wq wq wq wq wq wq wq
anz: Clayton’s Basic Pharmacology for Nurses, 19th Edition
wq wq wq wq wq wq wq
MULTIPLE CHOICE wq
1. Which name identifies a drug listed by the US Food
wq wq wq wq wq wq wq wq wq wq
and Drug Administration (FDA)?
wq wq wq
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C wq
The official name is the name under which a drug is lis
wq wq wq wq w q wq wq wq wq wq wq
ted by the FDA. The brand name, or trademark, is the n
wq wq wq wq wq wq wq wq wq wq wq
ame given to a drug by its manufacturer. The nonproprie
wq wq wq wq wq wq wq wq wq
tary, or generic, name is provided by the United States
wq wq wq wq wq wq wq wq wq wq
Adopted Names Council. wq wq
DIF: Cognitive Level: Knowledge REF: p. 9 wq wq wq wq
OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective C
wq wq wq wq wq wq wq wq
are Environment TOP: Nursing Process Step: Assessment
wq wq w q wq wq wq
CON: wq
Patient Education wq
2. Which source contains information specific to nutritional supplements?
wq wq wq wq wq wq wq
a. USP Dictionary of USAN & International Drug Names
wq wq wq wq wq wq wq
b. Natural Medicines Comprehensive Database wq wq wq
c. United States Pharmacopoeia/National Formulary (USP NF)
wq wq wq wq wq
d. Drug Interaction Facts wq wq
ANS: C wq
United States Pharmacopoeia/National Formulary contains information specific to nutrition
wq wq wq wq wq wq wq wq
al supplements. USP Dictionary of USAN & International Drug Names is a compilation
wq wq wq wq wq wq wq wq wq wq wq wq wq
of drug names, pronunciation guide, and possible future FDA approved drugs; it does no
wq wq wq wq wq wq wq wq wq wq wq wq wq
t include nutritional supplements. Natural Medicines Comprehensive Database contains
wq wq wq wq wq wq wq wq
evidence-
based information on herbal medicines and herbal combination products; it does not includ
wq wq wq wq wq wq wq wq wq wq wq wq
e information specific to nutritional supplements. Drug Interaction Facts contains compr
wq wq wq wq wq wq wq wq wq wq
ehensive information on drug interaction facts; it does not include nutritional supplement
wq wq wq wq wq wq wq wq wq wq wq
s.
DIF: Cognitive Level: Knowledge REF: p. 4 wq wq w q wq
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological
wq wq w q wq wq wq wq wq
Integrity
TOP: Nursing Process Step: Assessment CON: Nutrition | Patient Education
w q wq wq wq wq wq wq wq
3. Which drug reference contains drug monographs that describe all drugs in a therapeutic class?
wq wq wq wq wq wq wq wq wq wq wq wq wq
a. Drug Facts and Comparisons wq wq wq
,Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edit
wq wq wq wq wq wq wq wq wq 3
ion
b. Drug Interaction Facts wq wq
c. Handbook on Injectable Drugs wq wq wq
d. Martindale—The Complete Drug Reference wq wq wq
ANS: A wq
Drug Facts and Comparisons contains drug monographs that describe all drugs i
wq wq wq wq wq wq wq wq wq wq wq
n a therapeutic class. Monographs are formatted as tables to allow comparison of s
wq wq wq wq wq wq wq wq wq wq wq wq wq
imilar products, brand names, manufacturers, cost indices, and available dosage f
wq wq wq wq wq wq wq wq wq wq
orms Online version is available.
wq wq wq wq
DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 wq wq w q wq wq wq
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
w q w q wq wq wq wq wq wq
TOP: Nursing Process Step: Assessment CON: Safety | Patient Education | Clinical Judgment
w q wq wq wq wq wq wq wq wq wq wq
4. Which drug reference contains monographs about virtually every single-
wq wq wq wq wq wq wq wq
entity drug available in the United States and describes therapeutic uses of drugs, includ
wq wq wq wq wq wq wq wq wq wq wq wq wq
ing approved and unapproved uses?
wq wq wq wq
a. Martindale: The Complete Drug Reference wq wq wq wq
b. AHFS Drug Information wq wq
c. Drug Reference wq
d. Drug Facts and Comparisons
wq wq wq
ANS: B wq
AHFS Drug Information contains monographs about virtually every single-
wq wq wq wq wq wq wq wq
entity drug available in the United States and describes therapeutic uses of drugs, includin
wq wq wq wq wq wq wq wq wq wq wq wq wq
g approved and unapproved uses.
wq wq wq wq
DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 wq wq w q wq wq wq
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
w q w q wq wq wq wq wq wq
TOP: Nursing Process Step: Planning
w q CON: Safety | Patient Education | Clinical Judgment
wq wq wq wq wq wq wq wq wq wq
5. Which online drug reference makes available to healthcare providers and the public a
wq wq wq wq wq wq wq wq wq wq wq wq
standard, comprehensive, up-to-
wq wq wq
date look up and downloadable resource about medicines?
wq wq wq wq wq wq wq
a. American Drug Index wq wq
b. American Hospital Formulary wq wq
c. DailyMed
d. Drug Reference wq
ANS: C wq
DailyMed makes available to healthcare providers and the public a standard, comprehens
wq wq wq wq wq wq wq wq wq wq wq
ive, up-to-wq
date look up and downloadable resource about medicines. The American Drug Index is n
wq wq wq wq wq wq wq wq wq wq wq wq wq
ot appropriate for patient use. The American Hospital Formulary is not appropriate for
wq wq wq wq wq wq wq wq wq wq wq wq wq
patient use. The drug reference is not appropriate for patient use.
wq wq wq wq wq wq wq wq wq wq
DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4wq wq w q wq wq wq wq
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological
wq wq w q wq wq wq wq wq
Integrity
TOP: Nursing Process Step: Implementation
wq wq wq wq
CON: Safety | Patient Education | Clinical Judgment
wq wq wq wq wq wq wq
6. Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
a. Federal Food, Drug, and Cosmetic Act (1938)
wq wq wq wq wq wq
b. Durham Humphrey Amendment (1952) wq wq wq
, Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edit
wq wq wq wq wq wq wq wq wq 4
ion
c. Controlled Substances Act (1970) wq wq wq
d. Kefauver Harris Drug Amendment (1962) wq wq wq wq
ANS: A wq
The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine th
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
e safety of all drugs before marketing. Later amendments and acts helped tighten FDA c
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
ontrol and ensure drug safety. The Durham Humphrey Amendment defines the kinds of
wq wq wq wq wq wq wq wq wq wq wq wq wq
drugs that cannot be used safely without medical supervision and restricts their sale to p
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
rescription by a licensed practitioner. The Controlled Substances Act addresses only contro
wq wq wq wq wq wq wq wq wq wq wq
lled substances and their categorization. The Kefauver Harris Drug Amendment ensures d
wq wq wq wq wq wq wq wq wq wq wq
rug efficacy and greater drug safety. Drug manufacturers are required to prove to the FD
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
A the effectiveness of their products before marketing them.
wq wq wq wq wq wq wq wq
DIF: Cognitive Level: Knowledge REF: p. 5 Table l.3 wq wq w q wq wq wq
OBJ: 5 w q
NAT: NCLEX Client Needs Category: Physiological Integri wq wq wq wq wq wq
ty TOP: Nursing Process Step: Assessment
wq w q wq wq wq
CON: Safety | Patient Education | Evidence | Health Care Law
wq wq wq wq wq wq wq wq wq wq
7. Which classification does meperidine (Demerol) fall under?
wq wq wq wq wq wq
a. I
b. II
c. III
d. IV
ANS: B wq
Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may l
wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq
ead to severe psychological and physical dependence. Schedule I drugs have high potential
wq wq wq wq wq wq wq wq wq wq wq wq
for abuse and no recognized medical use. Schedule III drugs have some potential for ab
wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq
use. Use may lead to low to moderate physical dependence or high psychological depend
wq wq wq wq wq wq wq wq wq wq wq wq wq
ence. Schedule IV drugs have low potential for abuse. Use may lead to limited physical
wq wq wq wq wq wq wq wq wq wq wq wq wq wq w
or psychological dependence.
q wq wq
DIF: Cognitive Level: Knowledge REF: p. 10 wq wq w q wq
OBJ: 2 NAT: NCLEX Client Needs Category: Safe, Effective
wq wq wq wq wq wq wq wq w
Care Environment
q wq
TOP: Nursing Process Step: Assessment CON: Patient Education | Addiction | Pain
w q wq wq wq wq wq wq wq wq wq
8. Which action would the FDA take to expedite drug development and approval for an outb
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
reak of smallpox?
wq wq
a. List smallpox as a health orphan disease.
wq wq wq wq wq wq
b. Omit the preclinical research phase.
wq wq wq wq
c. Extend the clinical research phase. wq wq wq wq
d. Fast track the investigational drug.
wq wq wq wq
ANS: D wq
Once the Investigational New Drug Application has been approved, the drug can receive
wq wq wq wq wq wq wq wq wq wq wq wq
highest priority within the agency, which is called fast tracking. A smallpox outbreak
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
would become a priority concern in the world. Orphan diseases are not researched in a
wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq
priority manner. Preclinical research is not omitted. Extending any phase of the research
wq wq wq wq wq wq wq wq wq wq wq wq wq
would mean a longer time to develop a vaccine. The FDA must ensure that all phases of
wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq
the preclinical and clinical research phase have been completed in a safe manner.
wq wq wq wq wq wq wq wq wq wq wq wq
DIF: Cognitive Level: Knowledge wq wq REF: wqwq p. 7 wq OBJ: 5 wq
By Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton
Complete
,Chapter 01: Drug Definitions, Standards, and Information Sources Willihng
wq wq wq wq wq wq wq wq
anz: Clayton’s Basic Pharmacology for Nurses, 19th Edition
wq wq wq wq wq wq wq
MULTIPLE CHOICE wq
1. Which name identifies a drug listed by the US Food
wq wq wq wq wq wq wq wq wq wq
and Drug Administration (FDA)?
wq wq wq
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C wq
The official name is the name under which a drug is lis
wq wq wq wq w q wq wq wq wq wq wq
ted by the FDA. The brand name, or trademark, is the n
wq wq wq wq wq wq wq wq wq wq wq
ame given to a drug by its manufacturer. The nonproprie
wq wq wq wq wq wq wq wq wq
tary, or generic, name is provided by the United States
wq wq wq wq wq wq wq wq wq wq
Adopted Names Council. wq wq
DIF: Cognitive Level: Knowledge REF: p. 9 wq wq wq wq
OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective C
wq wq wq wq wq wq wq wq
are Environment TOP: Nursing Process Step: Assessment
wq wq w q wq wq wq
CON: wq
Patient Education wq
2. Which source contains information specific to nutritional supplements?
wq wq wq wq wq wq wq
a. USP Dictionary of USAN & International Drug Names
wq wq wq wq wq wq wq
b. Natural Medicines Comprehensive Database wq wq wq
c. United States Pharmacopoeia/National Formulary (USP NF)
wq wq wq wq wq
d. Drug Interaction Facts wq wq
ANS: C wq
United States Pharmacopoeia/National Formulary contains information specific to nutrition
wq wq wq wq wq wq wq wq
al supplements. USP Dictionary of USAN & International Drug Names is a compilation
wq wq wq wq wq wq wq wq wq wq wq wq wq
of drug names, pronunciation guide, and possible future FDA approved drugs; it does no
wq wq wq wq wq wq wq wq wq wq wq wq wq
t include nutritional supplements. Natural Medicines Comprehensive Database contains
wq wq wq wq wq wq wq wq
evidence-
based information on herbal medicines and herbal combination products; it does not includ
wq wq wq wq wq wq wq wq wq wq wq wq
e information specific to nutritional supplements. Drug Interaction Facts contains compr
wq wq wq wq wq wq wq wq wq wq
ehensive information on drug interaction facts; it does not include nutritional supplement
wq wq wq wq wq wq wq wq wq wq wq
s.
DIF: Cognitive Level: Knowledge REF: p. 4 wq wq w q wq
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological
wq wq w q wq wq wq wq wq
Integrity
TOP: Nursing Process Step: Assessment CON: Nutrition | Patient Education
w q wq wq wq wq wq wq wq
3. Which drug reference contains drug monographs that describe all drugs in a therapeutic class?
wq wq wq wq wq wq wq wq wq wq wq wq wq
a. Drug Facts and Comparisons wq wq wq
,Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edit
wq wq wq wq wq wq wq wq wq 3
ion
b. Drug Interaction Facts wq wq
c. Handbook on Injectable Drugs wq wq wq
d. Martindale—The Complete Drug Reference wq wq wq
ANS: A wq
Drug Facts and Comparisons contains drug monographs that describe all drugs i
wq wq wq wq wq wq wq wq wq wq wq
n a therapeutic class. Monographs are formatted as tables to allow comparison of s
wq wq wq wq wq wq wq wq wq wq wq wq wq
imilar products, brand names, manufacturers, cost indices, and available dosage f
wq wq wq wq wq wq wq wq wq wq
orms Online version is available.
wq wq wq wq
DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 wq wq w q wq wq wq
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
w q w q wq wq wq wq wq wq
TOP: Nursing Process Step: Assessment CON: Safety | Patient Education | Clinical Judgment
w q wq wq wq wq wq wq wq wq wq wq
4. Which drug reference contains monographs about virtually every single-
wq wq wq wq wq wq wq wq
entity drug available in the United States and describes therapeutic uses of drugs, includ
wq wq wq wq wq wq wq wq wq wq wq wq wq
ing approved and unapproved uses?
wq wq wq wq
a. Martindale: The Complete Drug Reference wq wq wq wq
b. AHFS Drug Information wq wq
c. Drug Reference wq
d. Drug Facts and Comparisons
wq wq wq
ANS: B wq
AHFS Drug Information contains monographs about virtually every single-
wq wq wq wq wq wq wq wq
entity drug available in the United States and describes therapeutic uses of drugs, includin
wq wq wq wq wq wq wq wq wq wq wq wq wq
g approved and unapproved uses.
wq wq wq wq
DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 wq wq w q wq wq wq
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
w q w q wq wq wq wq wq wq
TOP: Nursing Process Step: Planning
w q CON: Safety | Patient Education | Clinical Judgment
wq wq wq wq wq wq wq wq wq wq
5. Which online drug reference makes available to healthcare providers and the public a
wq wq wq wq wq wq wq wq wq wq wq wq
standard, comprehensive, up-to-
wq wq wq
date look up and downloadable resource about medicines?
wq wq wq wq wq wq wq
a. American Drug Index wq wq
b. American Hospital Formulary wq wq
c. DailyMed
d. Drug Reference wq
ANS: C wq
DailyMed makes available to healthcare providers and the public a standard, comprehens
wq wq wq wq wq wq wq wq wq wq wq
ive, up-to-wq
date look up and downloadable resource about medicines. The American Drug Index is n
wq wq wq wq wq wq wq wq wq wq wq wq wq
ot appropriate for patient use. The American Hospital Formulary is not appropriate for
wq wq wq wq wq wq wq wq wq wq wq wq wq
patient use. The drug reference is not appropriate for patient use.
wq wq wq wq wq wq wq wq wq wq
DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4wq wq w q wq wq wq wq
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological
wq wq w q wq wq wq wq wq
Integrity
TOP: Nursing Process Step: Implementation
wq wq wq wq
CON: Safety | Patient Education | Clinical Judgment
wq wq wq wq wq wq wq
6. Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
a. Federal Food, Drug, and Cosmetic Act (1938)
wq wq wq wq wq wq
b. Durham Humphrey Amendment (1952) wq wq wq
, Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edit
wq wq wq wq wq wq wq wq wq 4
ion
c. Controlled Substances Act (1970) wq wq wq
d. Kefauver Harris Drug Amendment (1962) wq wq wq wq
ANS: A wq
The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine th
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
e safety of all drugs before marketing. Later amendments and acts helped tighten FDA c
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
ontrol and ensure drug safety. The Durham Humphrey Amendment defines the kinds of
wq wq wq wq wq wq wq wq wq wq wq wq wq
drugs that cannot be used safely without medical supervision and restricts their sale to p
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
rescription by a licensed practitioner. The Controlled Substances Act addresses only contro
wq wq wq wq wq wq wq wq wq wq wq
lled substances and their categorization. The Kefauver Harris Drug Amendment ensures d
wq wq wq wq wq wq wq wq wq wq wq
rug efficacy and greater drug safety. Drug manufacturers are required to prove to the FD
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
A the effectiveness of their products before marketing them.
wq wq wq wq wq wq wq wq
DIF: Cognitive Level: Knowledge REF: p. 5 Table l.3 wq wq w q wq wq wq
OBJ: 5 w q
NAT: NCLEX Client Needs Category: Physiological Integri wq wq wq wq wq wq
ty TOP: Nursing Process Step: Assessment
wq w q wq wq wq
CON: Safety | Patient Education | Evidence | Health Care Law
wq wq wq wq wq wq wq wq wq wq
7. Which classification does meperidine (Demerol) fall under?
wq wq wq wq wq wq
a. I
b. II
c. III
d. IV
ANS: B wq
Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may l
wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq
ead to severe psychological and physical dependence. Schedule I drugs have high potential
wq wq wq wq wq wq wq wq wq wq wq wq
for abuse and no recognized medical use. Schedule III drugs have some potential for ab
wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq
use. Use may lead to low to moderate physical dependence or high psychological depend
wq wq wq wq wq wq wq wq wq wq wq wq wq
ence. Schedule IV drugs have low potential for abuse. Use may lead to limited physical
wq wq wq wq wq wq wq wq wq wq wq wq wq wq w
or psychological dependence.
q wq wq
DIF: Cognitive Level: Knowledge REF: p. 10 wq wq w q wq
OBJ: 2 NAT: NCLEX Client Needs Category: Safe, Effective
wq wq wq wq wq wq wq wq w
Care Environment
q wq
TOP: Nursing Process Step: Assessment CON: Patient Education | Addiction | Pain
w q wq wq wq wq wq wq wq wq wq
8. Which action would the FDA take to expedite drug development and approval for an outb
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
reak of smallpox?
wq wq
a. List smallpox as a health orphan disease.
wq wq wq wq wq wq
b. Omit the preclinical research phase.
wq wq wq wq
c. Extend the clinical research phase. wq wq wq wq
d. Fast track the investigational drug.
wq wq wq wq
ANS: D wq
Once the Investigational New Drug Application has been approved, the drug can receive
wq wq wq wq wq wq wq wq wq wq wq wq
highest priority within the agency, which is called fast tracking. A smallpox outbreak
wq wq wq wq wq wq wq wq wq wq wq wq wq wq
would become a priority concern in the world. Orphan diseases are not researched in a
wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq
priority manner. Preclinical research is not omitted. Extending any phase of the research
wq wq wq wq wq wq wq wq wq wq wq wq wq
would mean a longer time to develop a vaccine. The FDA must ensure that all phases of
wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq wq
the preclinical and clinical research phase have been completed in a safe manner.
wq wq wq wq wq wq wq wq wq wq wq wq
DIF: Cognitive Level: Knowledge wq wq REF: wqwq p. 7 wq OBJ: 5 wq
